ELI LILLY & Co is 954.4x more valuable than Zenas BioPharma, Inc. by market capitalization ($1.070 T vs $1.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ZBIO | LLY |
|---|---|---|
| Market cap | $1.12 B | $1.070 T |
| US-listed rank | #2561 | #10 |
| Revenue (latest FY) | $10.00M | $65.18B |
| Net income (latest FY) | -$377.74M | $20.64B |
| Net margin | -3777.4% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 166 | 989 |
ELI LILLY & Co is 954.4x more valuable than Zenas BioPharma, Inc. by market capitalization ($1.070 T vs $1.12 B).
In their latest fiscal years, Zenas BioPharma, Inc. reported $10.00M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Zenas BioPharma, Inc. and ELI LILLY & Co, or browse the full rankings.